Advanced search
Publication Cover
Journal of Inflammation Research Volume 16, 2023 - Issue
Submit an article Journal homepage
377
Views
6
CrossRef citations to date
0
Altmetric
Review

Potential Use of Janus Kinase Inhibitors in the Treatment of Systemic Lupus Erythematosus

Rongxiu HuoDepartment of Rheumatology and Immunology, Guangxi Academy of Medical Sciences, the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, People’s Republic of China
,
Xinxiang HuangDepartment of Rheumatology and Immunology, Guangxi Academy of Medical Sciences, the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, People’s Republic of China
,
Yang YangDepartment of Rheumatology and Immunology, Guangxi Academy of Medical Sciences, the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, People’s Republic of China
&
Jinying LinDepartment of Rheumatology and Immunology, Guangxi Academy of Medical Sciences, the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, People’s Republic of ChinaCorrespondence[email protected]
Pages 1471-1478 | Received 15 Nov 2022, Accepted 14 Mar 2023, Published online: 06 Apr 2023

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kate Tokareva, Pankti Reid, Victor Yang, David Liew, Alexander C. Peterson, Aaron Baraff, Jon Giles & Namrata Singh. (2023) JAK inhibitors and black box warnings: what is the future for JAK inhibitors?. Expert Review of Clinical Immunology 19:11, pages 1385-1397.
Read now

Articles from other publishers (5)

Tsvetelina Velikova, Dimitrina Miteva, Maria Kokudeva, Georgi H. Vasilev, Simeon Monov & Russka Shumnalieva. (2024) In the Pursuit of Precision: Novel Target Therapies Revolutionizing SLE Care. Rheumato 4:3, pages 120-136.
Crossref
Basma Ehab Amer, Eslam Afifi, Adel Mouffokes, Abdullah Ashraf Hamad, Ahmed Mostafa Amin & Omar Ahmed Abdelwahab. (2023) Does baricitinib reduce disease activity in patients with systemic lupus erythematosus? A systematic review and meta-analysis of randomized controlled trials. Clinical Rheumatology 43:2, pages 579-589.
Crossref
镱 盖. (2024) The Efficacy of Telitacicept in the Treatment of Patients with Systemic Lupus Erythematosus Combined with Antiphospholipid Syndrome. Advances in Clinical Medicine 14:05, pages 1648-1661.
Crossref
Chia‐Jen Lin, Yung‐Heng Lee, Po‐Cheng Shih & James Cheng‐Chung Wei. (2023) From concept to reality: CAR‐T therapy as a glimmer of hope for systemic lupus erythematosus patients . International Journal of Rheumatic Diseases 26:11, pages 2137-2140.
Crossref
Tong Li, Xianjing Yang, Juan Zhu, Ying Liu, Xiaobao Jin, Gong Chen & Lianbao Ye. (2023) Current application status and structure–activity relationship of selective and non-selective JAK inhibitors in diseases. International Immunopharmacology 122, pages 110660.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.